Muscle uridine diphosphate-hexosamines do not decrease despite correction of hyperglycemia-induced insulin resistance in type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 11, 2002, Pages 5179-5184

  Pouwels, Marie Jose J ^a,b   Span, Paul N ^a   Tack, Cees J ^a   Olthaar, André J ^a   Sweep, C G J ^a   Van Engelen, Baziel G ^a   De Jong, Jan G ^a   Lutterman, Jos A ^a   Hermus, Ad R ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; HEXOSAMINE; URIDINE DIPHOSPHATE; URIDINE DIPHOSPHATE GALACTOSE; URIDINE DIPHOSPHATE GLUCOSE; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG MUSCLE LEVEL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLYCOSYLATION; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN TREATMENT; MALE; METABOLIC REGULATION; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; BIOPSY; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLYCOSAMINOGLYCANS; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; ISOELECTRIC FOCUSING; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; TRANSFERRIN; URIDINE DIPHOSPHATE GALACTOSE; URIDINE DIPHOSPHATE GLUCOSE; URIDINE DIPHOSPHATE N-ACETYLGALACTOSAMINE; URIDINE DIPHOSPHATE N-ACETYLGLUCOSAMINE; URIDINE DIPHOSPHATE SUGARS;

ANIMALIA;

EID: 0036846535     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020440     Document Type: Article

References (27)

1. Rosseti L, Giaccari A, DeFronzo RA 1990 Glucose toxicity. Diabetes Care 13:610-630
2. McClain DA, Crook ED 1996 Hexosamines and insulin resistance. Diabetes 45:1003-1009
3. Rossetti L, Hawkins M, Chen W, Gindi J, Barzilai N 1995 In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. J Clin Invest 96:132-140
4. Robinson KA, Weinstein ML, Lindenmayer GE, Buse MG 1995 Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes 44:1438-1446
5. Hawkins M, Barzilai N, Liu R, Hu M, Chen W, Rossetti L 1997 Role of the glucosamine pathway in fat-induced insulin resistance. J Clin Invest 99:2173-2182
6. Garvey WT, Olefsky JM, Matthaei S, Marshall S 1987 Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance. J Biol Chem 262:189-197
7. Marshall S, Bacote V, Traxinger RR 1991 Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706-4712
8. Traxinger RR, Marshall S 1991 Coordinated regulation of glutamine:fructose-6-phosphate amidotransferase activity by insulin, glucose, and glutamine. J Biol Chem 266:10148-10154
9. Patti ME, Virkamäki A, Landaker EJ, Kahn CR, Yki-Järvinen H 1999 Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes 48:1562-1571
10. Hawkins M, Angelov I, Liu R, Barzilai N, Rossetti L 1997 The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake. J Biol Chem 272:4889-4895
11. Baron AD, Zhu JS, Zhu JH, Weldon H, Maianu L, Garvey WT 1995 Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity. J Clin Invest 96:2792-2801
12. Virkamäki A, Daniels MC, Hämäläinen S, Utriainen T, McClain D, Yki-Järvinen H 1997 Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues. Endocrinology 138:2501-2507
13. Daniels MC, Ciaraldi TP, Nikoulina S, Henry RR, McClain DA 1996 Glutamine:fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells: Relationship to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin. J Clin Invest 97:1235-1241
14. Yki-Järvinen H, Daniels MC, Virkamäki A, Mäkimatilla S, DeFronzo RA, McClain D 1996 Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM. Diabetes 45:302-307
15. DeFronzo RA, Tobin JD, Andres R 1979 Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
16. Span PN, Pouwels MJ, Olthaar AJ, Bosch RR, Hermus AR, Sweep CG 2001 Assay for hexosamine-pathway intermediates (uridine-diphosphate-N-acetyl amino-sugars) in small samples of human muscle tissue. Clin Chem 47:944-946
17. Grunewald S, Huyben K, de Jong JG, Smeitink JA, Rubio E, Boers GH, Conradt HS, Wendel U, Wevers RA 1999 β-Trace protein in human cerebro-spinal fluid: A diagnostic marker for N-glycosylation defects in brain. Biochim Biophys Acta 20:54-60
18. De Jong JG, Wevers RA, Laarakkers C, Poorthuis BJ 1989 Dimethylmethylene blue based spectrophotometry of glycosaminoglycans in untreated urine: A rapid screening procedure for mucopolysaccharidoses. Clin Chem 35:1472-1477
19. De Jong JG, Wevers RA, Liebrand-van Sambeek R 1992 Measuring urinary glycosaminoglycans in the presence of protein: An improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue. Clin Chem 38:803-807
20. Garvey TW, Olefsky JM, Griffin J, Hamman RF, Kolterman OG 1985 The effect of insulin treatment on insulin secretion and insulin action in type 2 DM. Diabetes 34:223-234
21. Yu JG, Kruszynska YT, Mulford MI, Olefsky JM 1999 A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin treated type 2 diabetic patients. Diabetes 48:2414-2421
22. Crook ED, Crenshaw G, Veerababu G, Sing LP 2000 Overexpression of glutamine:fructose-6-phosphate amidotransferase in rat-1 fibroblasts enhances glucose-mediated glycogen accumulation via suppression of glycogen phosphorylase activity. Endocrinology 141:1962-1970
23. Yki-Järvinen H, Virkamäki A, Daniels MC, McClain D, Gottschalk WK 1998 Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo. Metabolism 47:449-455
24. Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA 1987 Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 79:1510-1515
25. Monauni T, Zenti MG, Cretti A, Daniels MC, Targher G, Caruso B, Caputo M, McClain D, Del Prato S, Giaccari A, Muggeo M, Bonora E, Bonadonna RC 2000 Effects of glucosamine infusion on insulin secretion and insulto action in humans. Diabetes 49:926-935
26. Pouwels MJ, Jacobs JR, Span PN, Lutterman JA, Smits P, Tack CJ 2001 Short-term glucosamine infusion does not affect insulin sensitivity in humans. J Clin Endocrinol Metab 86:2099-2103
27. Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajansoski Z, Inzucchi S, Dresner A, Rothman DL, Shulman GI 1999 Impaired glucose transport as a cause of decreased insulin stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341:240-246